Kakish, H.H.; Ahmed, F.A.; Elshami, M.; Loftus, A.W.; Hoehn, R.S.; Ammori, J.B.; Ocuin, L.M.; Winter, J.M.; Bordeaux, J.S.; Mangla, A.;
et al. Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms? Cancers 2022, 14, 5184.
https://doi.org/10.3390/cancers14215184
AMA Style
Kakish HH, Ahmed FA, Elshami M, Loftus AW, Hoehn RS, Ammori JB, Ocuin LM, Winter JM, Bordeaux JS, Mangla A,
et al. Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms? Cancers. 2022; 14(21):5184.
https://doi.org/10.3390/cancers14215184
Chicago/Turabian Style
Kakish, Hanna H., Fasih Ali Ahmed, Mohamedraed Elshami, Alexander W. Loftus, Richard S. Hoehn, John B. Ammori, Lee M. Ocuin, Jordan M. Winter, Jeremy S. Bordeaux, Ankit Mangla,
and et al. 2022. "Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?" Cancers 14, no. 21: 5184.
https://doi.org/10.3390/cancers14215184
APA Style
Kakish, H. H., Ahmed, F. A., Elshami, M., Loftus, A. W., Hoehn, R. S., Ammori, J. B., Ocuin, L. M., Winter, J. M., Bordeaux, J. S., Mangla, A., & Rothermel, L. D.
(2022). Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms? Cancers, 14(21), 5184.
https://doi.org/10.3390/cancers14215184